The Late Effects We're Watching For (And Why They Exist)
Our son is a survivor. That word came into our family a little while ago, and it still doesn't quite fit in my mouth. It will, over time.
One of the parts of survivorship that isn't obvious from the outside is the follow-up calendar. Survivor children don't leave pediatric oncology when they finish active treatment. They graduate into a long-term follow-up program that monitors for the late effects of the drugs that saved them. Those appointments will be part of our son's life for years to come.
This post is about what survivorship monitoring looks like at home, why it exists, and why it is one of the strongest arguments for pediatric cancer research funding.
What late effects are
Late effects are health conditions that develop months, years, or sometimes decades after pediatric cancer treatment ends. They are caused by the treatments that produced the survival: chemotherapy, radiation, surgery, and the combined stress of long medical care on a growing body.
Between 60 and 90 percent of childhood cancer survivors develop at least one adverse health outcome traceable to their treatment. By the time survivors are in their 40s, roughly 88 percent have at least one chronic health condition linked to their cancer care. This is not a rare complication. This is the pattern.
The good news is that late-effect rates have improved over time as protocols have gotten smarter. Severe or life-threatening late effects within 15 years of diagnosis dropped from 12.7 percent for survivors diagnosed in the 1970s, to 10.1 percent in the 1980s, to 8.9 percent in the 1990s. That improvement came from research. It also came, importantly, from using the same essential drugs more carefully rather than from new drugs.
There is a ceiling to how much smarter use can help.
What survivorship clinic watches
Every survivor has a slightly different follow-up plan based on their specific diagnosis, the drugs they received, and their cumulative exposures. The Children's Oncology Group publishes long-term follow-up guidelines that pediatric survivorship clinics use to shape each survivor's monitoring schedule.
The most common categories survivorship clinic watches for:
Growth and endocrine
Chemotherapy and steroids can affect growth patterns, puberty timing, thyroid function, and other endocrine systems. Survivors are typically followed by their oncologist and, if needed, by pediatric endocrinology.
Bone health
Long-term steroid use during treatment can affect bone density and, in some cases, cause avascular necrosis (bone tissue damage). Prednisone and dexamethasone, both used in many pediatric protocols, are well-known for this. Survivorship clinic often includes bone density monitoring for children who had significant steroid exposure.
Neurocognitive
Certain chemotherapy drugs, especially methotrexate delivered into the central nervous system via spinal tap (called intrathecal methotrexate), have been associated with neurocognitive changes in some pediatric survivors. Attention, processing speed, working memory. Survivorship programs often include neuropsychological evaluation, particularly for children who had CNS-directed therapy.
Cardiac
For survivors who received anthracyclines (doxorubicin, daunorubicin, others), long-term cardiac monitoring is standard. Anthracyclines are known to be cardiotoxic. Research on pediatric patients treated with anthracyclines has shown that as many as 40 percent can have subclinical cardiac dysfunction detectable on follow-up, and 5 to 10 percent may develop congestive heart failure in the years or decades after treatment. Survivorship for these children includes echocardiograms on a schedule set by pediatric cardiology.
Liver, kidney, and blood counts
Some chemotherapy drugs place ongoing stress on the liver and kidneys. Survivorship clinics often include periodic bloodwork to monitor liver enzymes, kidney function, and complete blood counts.
Peripheral neuropathy
Vinca alkaloids like vincristine, used in almost every pediatric acute lymphoblastic leukemia protocol, can cause peripheral neuropathy. In most children this resolves after treatment ends. In some it lingers. Fine motor skills, gait, or subtle nerve function may be monitored during survivorship visits.
Fertility
Some chemotherapy drugs and radiation exposures can affect future fertility. This is a conversation that starts in survivorship clinic and evolves as children grow into adolescence and adulthood.
Secondary cancers
Childhood cancer survivors have a slightly elevated risk of developing a different cancer later in life, related to their initial cancer treatment. The risk is small for most survivors, but real, and survivorship clinics include appropriate screening as survivors age.
Mental health
Pediatric cancer survivors are at elevated risk for anxiety, depression, and post-traumatic stress. So are their parents. So are their siblings. Survivorship care often includes mental health screening and referrals.
Why this all traces back to the drug-age problem
Every category above is a category we monitor because the chemotherapy drugs used in pediatric cancer are, for the most part, drugs developed in the 1950s, 60s, and 70s. Vincristine, 6-mercaptopurine, methotrexate, cyclophosphamide, doxorubicin, prednisone, dexamethasone. All essential. All from an earlier era of medicine. All with long-term effects we now have decades of data on.
In a world where pediatric cancer research had received funding proportional to the size of the problem over the last 50 years, we might have gentler, more targeted treatments today. Drugs designed for pediatric bodies from the start. Immunotherapies calibrated for pediatric use in mind. Precision medicine approaches that attack the cancer without the collateral damage.
We are getting there in fits and starts. CAR-T therapy (Kymriah, approved 2017 for pediatric relapsed leukemia) is a genuine example of what dedicated pediatric research produces. But CAR-T is one drug for one specific indication. The rest of the pediatric cancer drug landscape still leans heavily on the older workhorse chemotherapies.
Every survivorship appointment on every survivor family's calendar is, in one sense, a small piece of evidence for why more research funding matters. Not because our children weren't saved. They were. Because the children who survive next deserve to need fewer of these follow-up appointments over the course of their lives.
What our family's survivorship rhythm looks like
Our own survivorship calendar has a small number of standing appointments each year. We know when they are. We prepare for them. We have small rituals around them. Coffee before. A quiet walk after. My husband and I don't talk about the results until we're home.
For the first year post-treatment, I dreaded them. It's a little easier now. Not because the stakes are lower. Because we've built a rhythm.
This is what modern survivorship looks like when you have children surviving pediatric cancer in numbers we didn't use to see, being followed carefully because we know what the older drugs can do over time. The follow-up is a good thing. It is also a marker of how much surveillance a modern survivorship pathway requires.
For other survivor families
If you're new to survivorship care and the follow-up calendar feels overwhelming, you're not alone. Every survivor family has some version of this. A heart appointment. A hearing appointment. A cognitive testing appointment. An endocrine appointment. A dermatology screening. Something.
The best thing we've found for the dread is community. Talk to other survivor moms about their monitoring schedule. Compare notes. Share small strategies. Ask them how they've made peace with the annual checks. Nobody wants to be in this community. It is also, hands down, one of the greatest communities to be part of. Survivor families become each other's medical guides, emotional anchors, and long-term friends.
Dina
Mom of Max | Founder, Maxwell’s Toy Shoppe
Childhood Cancer Advocate 💛
Follow Us On Social
Join our movement to support children battling cancer and their families, year-round:
🎁 Donate to deliver toys to children during long cancer treatment days
🧸 Buy a toy from Maxwell’s Toy Shoppe, and 100% of proceeds support children in treatment
🎗️ Join Maxwell’s Circle of Heroes as a monthly donor to ensure families receive ongoing care
